世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

創傷治療市場:製品(ドレッシング(フォーム、フィルム、ハイドロコロイド、コラーゲン)、デバイス(NPWT、アセスメント、デブリードメント)、グラフト、マトリックス、縫合、ステープラー)、傷(DFU、外傷、外科、熱傷)、エンドユーザー(病院、診療所)、地域別 - 2027年までの世界市場予測


Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region - Global Forecast to 2027

世界の創傷治療市場は、2022年の208億米ドルから2027年には272億米ドルに達すると予測され、予測期間中のCAGRは5.4%となります。市場成長の背景には、外傷の増加、手術創の増加、外傷の管理に対する支出の増加と... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ
2022年6月16日 US$8,150
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
308 287 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

世界の創傷治療市場は、2022年の208億米ドルから2027年には272億米ドルに達すると予測され、予測期間中のCAGRは5.4%となります。市場成長の背景には、外傷の増加、手術創の増加、外傷の管理に対する支出の増加といった要因があります。一方、創傷治療製品のバリデーションに関連する課題や熟練した専門家の不足が、この市場の成長を妨げる主な要因となっています。
"予測期間中の創傷ケア市場の製品別成長率では、高度創傷ケア製品分野が最も高い成長率を占めている"
創傷ケア市場は、先進的な創傷ケア製品、外科的創傷ケア製品、従来の創傷ケア製品に区分されます。2021年の創傷ケア市場では、先進的な創傷ケア製品分野が最も高い成長率を占めています。外傷や手術創の発生率の増加が、このセグメントの成長に寄与する主な要因となっています。
"傷の種類別では、糖尿病性足潰瘍分野が予測期間中、創傷ケア市場で最も高い成長率を占めた"
創傷ケア市場は、創傷タイプに基づいて、外科・外傷性創傷、糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍、火傷・その他の創傷に区分されます。2021年の創傷治療市場では、糖尿病性足潰瘍分野が最も高い成長率を占めています。がんバイオマーカーの開発における技術的進歩の高まりと、糖尿病やその他の健康状態の発生率の増加が、このセグメントの成長に寄与する主な要因です。
"病院・クリニック分野が最も高いシェアを占める"
エンドユーザーに基づいて、創傷ケア市場は、病院やクリニック、長期患者ケア、ホームケア設定、その他のエンドユーザーに区分されています。2021年には、ホームケア設定セグメントが最も高いCAGRを占めた。これは、外科的創傷への注目が高まっていることに起因すると考えられる。

"アジア太平洋地域。創傷ケア市場で最も成長率の高い地域"
世界の創傷治療市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに区分されます。アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると予測されています。手術創の減少に向けた注目度の高まりと、外傷創の管理に対する関心の高まりが、この地域の創傷治療市場の成長を後押ししています。

本レポートのために実施した主なインタビューは、以下のように分類することができます。

- 企業タイプ別Tier 1 - 40%, Tier 2 - 30%, Tier 3 - 30
- 役職別Cレベル:27%、Dレベル:18%、その他:55
- 地域別北米:51%、欧州:21%、アジア太平洋:18%、中南米:6%、中東・アフリカ:4
レポート掲載企業リスト

- 3M カンパニー(米国)
- スミス・アンド・ネフューPLC(英国)
- カーディナル・ヘルス(米国)
- メドトロニックPLC(アイルランド)
- ブラウン・メルスンゲン社(ドイツ)
- バクスターインターナショナルインク(アメリカ)
- メルンリッケヘルスケアAB(スウェーデン)
- コンバテックグループ(英国)
- ポールハルトマンAG(ドイツ)
- コロプラストA/S(デンマーク)
- オーガノジェネシスホールディングス(米国)
- ミメデックスグループ(米国)
- インテグラ・ライフサイエンス・ホールディングス・コーポレーション(米国)
- バイオベンタス社(米国)
- ジンマー・バイオメット・ホールディングス(米国)
- エシコン社(米国)
- デロイヤル・インダストリーズ社(米国)
- ケレシス(アイスランド)
- アセル社(米国)
- ローマン&ラウシャー社(ドイツ) Lohmann & Rauscher GmbH & Co.KG(ドイツ)
- メデラアグ(スイス)
- タリーグループ(イギリス)
- ウェルケア インダストリーズ SPA(イタリア)
- 武漢VSD医学科学技術有限公司(武漢市Ltd.(中国)
- ペンサール・メディカル(米国)
- ハロメッドBVBA(ベルギー)
- DermaRite Industries LLC(米国)
- メドライン・インダストリーズ社(米国)
- アドバンシス・メディカル LLC(英国)
- ミルラボラトリーズPvt.Ltd.(インド)です。
調査対象範囲
本レポートでは、世界の創傷治療市場の詳細な実態を把握することができます。製品、創傷タイプ、エンドユーザー、地域など、さまざまなセグメントにおける市場規模と今後の成長可能性を推計することを目的としています。また、主要市場プレイヤーの企業プロファイル、最近の開発状況、主要市場戦略とともに、詳細な競合分析も行っています。

レポート購入の主な利点
本レポートは、創傷ケア市場全体とそのサブセグメントに関する収益数の最も近い概算を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競合状況をより良く理解し、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるためのより多くの洞察を得るのに役立ちます。本レポートは、利害関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を提供することを可能にします。

ページTOPに戻る


目次

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 36
1.3 MARKETS COVERED 37
1.3.1 WOUND CARE MARKET 37
1.3.2 YEARS CONSIDERED FOR THE STUDY 38
1.4 CURRENCY 38
1.5 LIMITATIONS 38
1.6 STAKEHOLDERS 39
1.7 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.2 RESEARCH APPROACH 40
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN METHODOLOGY 40
2.2.1 SECONDARY DATA 41
2.2.1.1 Key data from secondary sources 41
2.2.2 PRIMARY DATA 42
2.2.2.1 Primary sources 42
2.2.2.2 Key data from primary sources 43
2.2.2.3 Key industry insights 44
2.2.2.4 Breakdown of primary interviews 44
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Approach 1: Company revenue estimation approach 46
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 46
2.3.1.2 Approach 3: Presentations of companies and primary interviews 46
2.3.1.3 Growth forecast 47
2.3.1.4 CAGR projections 47
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
2.3.2 TOP-DOWN APPROACH 47
FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH 48

2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49
FIGURE 7 DATA TRIANGULATION METHODOLOGY 49
2.5 MARKET SHARE 50
2.6 ASSUMPTIONS FOR THE STUDY 50
2.7 LIMITATIONS 51
2.8 GROWTH RATE ASSUMPTIONS 51
2.9 RISK ASSESSMENT 51
2.9.1 RISK ASSESSMENT: WOUND CARE MARKET 51
3 EXECUTIVE SUMMARY 52
FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2022 VS. 2027 (USD MILLION) 53
FIGURE 10 WOUND CARE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53
FIGURE 11 WOUND CARE MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 54
4 PREMIUM INSIGHTS 55
4.1 WOUND CARE MARKET OVERVIEW 55
FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE THE MARKET GROWTH 55
4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2022 VS. 2027 55
FIGURE 13 THE ADVANCED WOUND CARE PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 55
4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2022 VS. 2027 56
FIGURE 14 SURGICAL & TRAUMATIC SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 56
4.4 WOUND CARE MARKET SHARE, BY END USER, 2022 VS. 2027 56
FIGURE 15 THE HOSPITALS AND CLINICS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 56
4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
FIGURE 16 THE ASIA PACIFIC REGION IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 58
5.2.1 DRIVERS 59
5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities 59
5.2.1.1.1 Growing geriatric population 59
5.2.1.1.2 Rising prevalence of diabetes 60
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2045 (MILLION CASES) 60
5.2.1.1.3 Increasing number of surgical procedures worldwide 60
TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES
PERFORMED IN THE US 61
5.2.2 RISING EXPENDITURE ON CHRONIC WOUNDS 62
5.2.3 INCREASING INCIDENCE OF BURN INJURIES 62
5.2.4 RISING CASES OF TRAUMATIC INJURIES 63
TABLE 2 PREVALENCE OF ROAD ACCIDENTS 63
5.2.5 TECHNOLOGICAL ADVANCEMENTS IN WOUND CARE PRODUCTS 63
5.2.6 RISING USE OF REGENERATIVE MEDICINE FOR WOUND MANAGEMENT 64
5.2.7 RESTRAINTS 65
5.2.7.1 High costs of advanced wound care products 65
TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS 65
5.2.7.2 Risks associated with the use of advanced wound care products 65
TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 66
5.2.8 OPPORTUNITIES 66
5.2.8.1 Growth potential of emerging countries 66
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC REGION 66
5.2.9 TRENDS 67
5.2.9.1 Acquisitions by leading companies in the market 67
5.2.9.1.1 Rising focus on expanding current technologies and launching novel products 68
5.2.9.1.2 Smart wound dressings for minimum invasiveness 68
5.2.9.1.3 Crab shell bandages 68
5.2.9.1.4 Color-changing dressings 69
5.2.9.1.5 Integration of nanotechnology in advanced wound care products 69
5.2.9.1.6 Novel wound assessment & measurement devices 69
5.3 IMPACT OF COVID-19 ON THE WOUND CARE MARKET 69
5.4 PRICING ANALYSIS 70
TABLE 6 AVERAGE SELLING PRICE OF WOUND CARE PRODUCTS (2022) 70
5.5 PATENT ANALYSIS 71
FIGURE 19 PATENT ANALYSIS OF THE WOUND CARE MARKET 71
5.5.1 LIST OF MAJOR PATENTS 72
5.6 VALUE CHAIN ANALYSIS 72
FIGURE 20 VALUE CHAIN ANALYSIS OF THE WOUND CARE MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 73
5.7 SUPPLY CHAIN ANALYSIS 73
FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 74
5.8 ECOSYSTEM/MARKET MAP 74
FIGURE 22 WOUND CARE MARKET: ECOSYSTEM/MARKET MAP 75
5.8.1 WOUND CARE MARKET: ECOSYSTEM ROLE 75
5.9 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 7 WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 76
5.9.1 THREAT FROM NEW ENTRANTS 76
5.9.2 THREAT FROM SUBSTITUTES 76
5.9.3 BARGAINING POWER OF BUYERS 76
5.9.4 BARGAINING POWER OF SUPPLIERS 77
5.9.5 DEGREE OF COMPETITION 77
5.10 REGULATORY LANDSCAPE 77
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.10.1 NORTH AMERICA 78
5.10.1.1 US 78
5.10.1.2 Canada 79
5.10.2 EUROPE 79
5.10.3 ASIA PACIFIC 79
5.10.3.1 China 79
5.10.3.2 Japan 79
5.10.3.3 India 79
5.10.4 LATIN AMERICA 79
5.10.4.1 Brazil 80
5.10.4.2 Mexico 80
5.10.5 MIDDLE EAST 80
5.10.6 AFRICA 80
5.11 TRADE ANALYSIS 81
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 81
5.11.1.1 Import data for adhesive dressings by country,
2017–2021 (USD million) 81
5.11.1.2 Export data for adhesive dressings by country,
2017–2021 (USD million) 81
5.12 TECHNOLOGY ANALYSIS 81
5.13 KEY CONFERENCES & EVENTS IN 2022–2023 82
TABLE 12 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 82
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 84
5.14.2 REVENUE SHIFT IN THE WOUND CARE MARKET 84
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 85
5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 85
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS 85
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS (%) 85
5.15.2 BUYING CRITERIA 86
FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 86
TABLE 14 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 86
5.16 CASE STUDIES 87
5.16.1 CASE STUDY: TIELLE ESSENTIAL SILICONE FOAM DRESSINGS USED IN A NON-HEALING DIABETIC FOOT ULCER ON THE RIGHT FOOT 87
6 WOUND CARE MARKET, BY PRODUCT 88
6.1 INTRODUCTION 89
TABLE 15 WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
6.1.1 PRIMARY NOTES 89
6.1.1.1 Key industry insights 89
6.2 ADVANCED WOUND CARE PRODUCTS 90
TABLE 16 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 90
TABLE 17 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 91
6.2.1 ADVANCED WOUND CARE DRESSINGS 91
TABLE 18 ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 92
TABLE 19 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION) 93
6.2.1.1 Foam dressings 93
TABLE 20 KEY PRODUCTS IN THE FOAM DRESSINGS MARKET 93
TABLE 21 FOAM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 22 FOAM DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
6.2.1.1.1 Silicone dressings 95
6.2.1.1.1.1 Silicone dressings help expedite wound closure and reduce the risk of maceration – a key factor driving the market growth 95
TABLE 23 SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
6.2.1.1.2 Non-silicone dressings 97
6.2.1.1.2.1 Non-silicone dressings are effective in scar removal and wound healing 97
TABLE 24 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
6.2.1.2 Hydrocolloid dressings 98
6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment which is required for optimal healing 98
TABLE 25 KEY PRODUCTS IN THE HYDROCOLLOID DRESSINGS MARKET 98
TABLE 26 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
6.2.1.3 Film dressings 99
6.2.1.3.1 The non-absorbable nature of film dressings ensures strong adoption 99
TABLE 27 FILM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.2.1.4 Alginate dressings 100
6.2.1.4.1 Alginate dressings are well suited for diabetic & foot ulcers 100
TABLE 28 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
6.2.1.5 Hydrogel dressings 102
6.2.1.5.1 Hydrogel dressings are available in several forms for effective use 102
TABLE 29 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.2.1.6 Collagen dressings 103
6.2.1.6.1 A favorable reimbursement scenario for collagen dressings to support the market growth 103
TABLE 30 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.2.1.7 Hydrofiber dressings 104
6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and collagen 104
TABLE 31 HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
6.2.1.8 Wound contact layers 105
6.2.1.8.1 Wound contact layers protect wound beds from bacterial & fungal growth 105
TABLE 32 WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 106
6.2.1.9 Superabsorbent dressings 106
6.2.1.9.1 Superabsorbent dressings are designed for highly exuding wounds 106
TABLE 33 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 107
6.2.1.10 Other advanced wound care dressings 107
TABLE 34 OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 109
TABLE 35 ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 36 NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
TABLE 37 ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
6.2.2 WOUND THERAPY DEVICES 111
TABLE 38 WOUND THERAPY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 111
TABLE 39 WOUND THERAPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
6.2.2.1 Portable & conventional negative pressure wound therapy devices (NPWT) 112
6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare to drive the market growth 112
TABLE 40 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 113
6.2.2.2 Debridement devices & accessories 113
6.2.2.2.1 Development of novel technologies to support the growth of this segment 113
TABLE 41 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 114
6.2.2.3 Wound assessment & monitoring devices 115
6.2.2.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost its adoption 115
TABLE 42 WOUND ASSESSMENT & MONITORING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 115
6.2.3 OTHER DEVICES & ACCESSORIES 116
TABLE 43 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 117
6.2.4 GRAFTS & MATRICES 117
6.2.4.1 Grafts & matrices promote healing & wound closure 117
TABLE 44 KEY PRODUCTS IN THE GRAFTS & MATRICES MARKET 118
TABLE 45 GRAFTS & MATRICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
6.2.5 TOPICAL AGENTS 119
6.2.5.1 Cost-effectiveness & ease-of-use in home care settings to drive the growth of this segment 119
TABLE 46 TOPICAL AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
6.3 SURGICAL WOUND CARE PRODUCTS 120
TABLE 47 SURGICAL CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 121
TABLE 48 SURGICAL CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
6.3.1 SUTURES 122
6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures drive the market growth 122
TABLE 49 SUTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
6.3.2 STAPLERS 123
6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage; a key factor driving adoption 123
TABLE 50 STAPLERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES 125
TABLE 51 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 126
TABLE 52 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION,
2020–2027 (USD MILLION) 127
6.3.3.1 Fibrin-based sealants 127
6.3.3.1.1 Fibrin-based sealants provide better results than sutures, thus driving the product demand 127
TABLE 53 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 128
6.3.3.2 Collagen-based sealants 128
6.3.3.2.1 Collagen-based sealants are used in surgical procedures as an adjunctive to hemostatic agents 128
TABLE 54 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 129
6.3.3.3 Synthetic adhesives 129
6.3.3.3.1 Synthetic adhesives have additional sealing properties than traditional staples; a key factor driving the segment growth 129
TABLE 55 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.4 TRADITIONAL WOUND CARE PRODUCTS 131
TABLE 56 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 131
TABLE 57 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 132
6.4.1 MEDICAL TAPES 132
6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients 132
TABLE 58 MEDICAL TAPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
6.4.2 DRESSINGS 133
6.4.2.1 Presence of a large patient population for pressure ulcers has ensured a sustained demand for these products 133
TABLE 59 DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
6.4.3 CLEANSING AGENTS 134
6.4.3.1 High risk of HAIs from open wounds to drive the market growth 134
TABLE 60 TYPES OF CLEANSING AGENTS 135
TABLE 61 CLEANSING AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
7 WOUND CARE MARKET, BY WOUND TYPE 136
7.1 INTRODUCTION 137
TABLE 62 WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION) 137
7.2 SURGICAL & TRAUMATIC WOUNDS 137
7.2.1 THE RISING VOLUME OF SURGICAL PROCEDURES DRIVES THE GROWTH OF THIS SEGMENT 137
TABLE 63 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,
BY COUNTRY, 2020–2027 (USD MILLION) 138
7.3 DIABETIC FOOT ULCERS 139
7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT 139
TABLE 64 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN
2021 (20-79 AGE GROUP) 139
TABLE 65 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 140
7.4 PRESSURE ULCERS 140
7.4.1 GROWING GERIATRIC POPULATION TO DRIVE THE GROWTH OF THIS SEGMENT 140
TABLE 66 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 142
7.5 VENOUS LEG ULCERS 142
7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE THE GROWTH OF THIS SEGMENT 142
TABLE 67 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 143

7.6 BURNS AND OTHER WOUNDS 144
7.6.1 HIGH INCIDENCE OF BURN INJURIES TO DRIVE THE MARKET GROWTH 144
TABLE 68 WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY,
2020–2027 (USD MILLION) 145
8 WOUND CARE MARKET, BY END USER 146
8.1 INTRODUCTION 147
TABLE 69 WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 147
8.2 HOSPITALS AND CLINICS 147
TABLE 70 TOTAL NUMBER OF HOSPITALS, BY COUNTRY (IN 2019) 148
TABLE 71 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 72 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY TYPE,
2020–2027 (USD MILLION) 149
8.2.1 INPATIENT SETTINGS 150
8.2.1.1 Increasing hospital admissions due to HAIs to drive the growth of this segment 150
TABLE 73 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 150
8.2.2 OUTPATIENT SETTINGS 151
8.2.2.1 Rising costs of inpatient facilities drive the demand for outpatient care settings 151
TABLE 74 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 151
8.3 HOME CARE SETTINGS 152
8.3.1 LOW COSTS AND CONVENIENCE TO DRIVE THE GROWTH OF
THIS END-USER SEGMENT 152
TABLE 75 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 153
8.4 LONG-TERM CARE FACILITIES 153
8.4.1 GROWTH IN THE GERIATRIC & VULNERABLE POPULATIONS DRIVES THE DEMAND FOR BETTER LONG-TERM CARE 153
TABLE 76 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 154
8.5 OTHER END USERS 154
TABLE 77 WOUND CARE MARKET FOR OTHER END-USERS, BY COUNTRY,
2020–2027 (USD MILLION) 155
9 WOUND CARE MARKET, BY REGION 156
9.1 INTRODUCTIONS 157
TABLE 78 WOUND CARE MARKET, BY REGION, 2020–2027 (USD MILLION) 157
9.2 NORTH AMERICA 157
FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT 158
TABLE 79 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 159
TABLE 80 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 159
TABLE 81 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 159
TABLE 82 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 160
TABLE 83 NORTH AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 160
TABLE 84 NORTH AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 161
TABLE 85 NORTH AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 161
TABLE 86 NORTH AMERICA: WOUND CARE MARKET; BY TISSUES ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 162
TABLE 87 NORTH AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 162
TABLE 88 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 162
TABLE 89 NORTH AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 163
9.2.1 US 163
9.2.1.1 Rising incidence of chronic diseases and diabetes to
drive the market growth 163
TABLE 90 US: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 163
TABLE 91 US: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 164
9.2.2 CANADA 164
9.2.2.1 High prevalence of HAIs drives the market growth for wound care management in Canada 164
TABLE 92 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029 164
TABLE 93 CANADA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 94 CANADA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 165
9.3 EUROPE 166
TABLE 95 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP) 166
TABLE 96 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045 167
TABLE 97 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 167
TABLE 98 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 168
TABLE 99 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 168
TABLE 100 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 169
TABLE 101 EUROPE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 169
TABLE 102 EUROPE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 170
TABLE 103 EUROPE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 170
TABLE 104 EUROPE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 171
TABLE 105 EUROPE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 171
TABLE 106 EUROPE: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 171
TABLE 107 EUROPE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 172
9.3.1 GERMANY 172
9.3.1.1 The large diabetic population in Germany has supported product development & commercialization for the wound care market 172
TABLE 108 GERMANY: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 173
TABLE 109 GERMANY: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 173
9.3.2 FRANCE 173
9.3.2.1 The rising senior population drives the market growth in France 173
TABLE 110 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 111 FRANCE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 174
9.3.3 UK 174
9.3.3.1 Rising incidence of chronic wounds to propel market growth in the UK 174
TABLE 112 UK: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 113 UK: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 175
9.3.4 ITALY 176
9.3.4.1 Growth in this market is driven by improving quality & accessibility to medical care and products 176
TABLE 114 ITALY: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 176
TABLE 115 ITALY: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 177
9.3.5 SPAIN 177
9.3.5.1 Increasing life expectancies and the growing geriatric population to ensure the market growth in Spain 177
TABLE 116 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178
TABLE 117 SPAIN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 178
9.3.6 RUSSIA 178
9.3.6.1 Government focus on increasing diabetes awareness to favor the market growth 178
TABLE 118 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 179
TABLE 119 RUSSIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 179
9.3.7 REST OF EUROPE 179
TABLE 120 ROE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 121 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE
PRODUCTS, 2020–2027 (USD MILLION) 180
TABLE 122 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 181
TABLE 123 ROE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 181
TABLE 124 ROE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 182
TABLE 125 ROE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 182
TABLE 126 ROE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 183
TABLE 127 ROE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 183
TABLE 128 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION) 183
TABLE 129 ROE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 184
9.4 ASIA PACIFIC 184
FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT 185
TABLE 130 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 186
TABLE 131 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 186
TABLE 132 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 186
TABLE 133 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 187
TABLE 134 ASIA PACIFIC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 187
TABLE 135 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 188
TABLE 136 ASIA PACIFIC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 188
TABLE 137 ASIA PACIFIC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 189
TABLE 138 ASIA PACIFIC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 189
TABLE 139 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 189
TABLE 140 ASIA PACIFIC: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 190
9.4.1 CHINA 190
9.4.1.1 Increasing incidence of DFUs to support the market growth in China 190
TABLE 141 CHINA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 191
TABLE 142 CHINA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 191
9.4.2 JAPAN 191
9.4.2.1 Implementations of regulations in Japan have resulted in a favorable environment for wound care devices 191
TABLE 143 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 192
TABLE 144 JAPAN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 192
9.4.3 INDIA 193
9.4.3.1 Growing medical tourism in India to support the market growth for wound care management 193
TABLE 145 INDIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 193
TABLE 146 INDIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 194
9.4.4 AUSTRALIA 194
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support the market growth 194
TABLE 147 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 195
TABLE 148 AUSTRALIA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 195
9.4.5 SOUTH KOREA 195
9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for advanced wound care products; a key growth driver 195
TABLE 149 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 196
TABLE 150 SOUTH KOREA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 196
9.4.6 SINGAPORE 196
9.4.6.1 The growing prevalence of diabetes drives the market growth in Singapore 196
TABLE 151 SINGAPORE: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 197
TABLE 152 SINGAPORE: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 197
9.4.7 REST OF ASIA PACIFIC 197
TABLE 153 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 198
TABLE 154 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 198
TABLE 155 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 199
TABLE 156 ROAPAC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 199
TABLE 157 ROAPAC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 200
TABLE 158 ROAPAC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 200
TABLE 159 ROAPAC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 201
TABLE 160 ROAPAC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 201
TABLE 161 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 201
TABLE 162 ROAPAC: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 202
9.5 LATIN AMERICA 202
TABLE 163 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 202
TABLE 164 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 203
TABLE 165 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 203
TABLE 166 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 204
TABLE 167 LATIN AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 204
TABLE 168 LATIN AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 205
TABLE 169 LATIN AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 205
TABLE 170 LATIN AMERICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 206
TABLE 171 LATIN AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 206
TABLE 172 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 206
TABLE 173 LATIN AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 207
9.5.1 BRAZIL 207
9.5.1.1 Brazil is the largest healthcare market in Latin America 207
TABLE 174 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 207
TABLE 175 BRAZIL: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 208
9.5.2 MEXICO 208
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico 208
TABLE 176 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 208
TABLE 177 MEXICO: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 209
9.5.3 REST OF LATIN AMERICA 209
TABLE 178 ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 209
TABLE 179 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 210
TABLE 180 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 210
TABLE 181 ROLATAM: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 211
TABLE 182 ROLATAM: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 211
TABLE 183 ROLATAM: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 212
TABLE 184 ROLATAM: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 212
TABLE 185 ROLATAM: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 212
TABLE 186 ROLATAM: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 213
TABLE 187 ROLATAM: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 213

9.6 MIDDLE EAST & AFRICA 213
9.6.1 RISING PREVALENCE OF DIABETES IN THE REGION TO SUPPORT
THE MARKET GROWTH 213
TABLE 188 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 214
TABLE 189 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 214
TABLE 190 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 215
TABLE 191 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION) 215
TABLE 192 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 216
TABLE 193 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 216
TABLE 194 MIDDLE EAST & AFRICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 217
TABLE 195 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY TRADITIONAL
WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 217
TABLE 196 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 217
TABLE 197 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 218
10 COMPETITIVE LANDSCAPE 219
10.1 OVERVIEW 219
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 219
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE WOUND CARE MARKET 219
TABLE 198 OVERVIEW OF STRATEGIES DEPLOYED BY KEY WOUND CARE MANUFACTURING COMPANIES 219
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 221
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET 221
10.4 MARKET SHARE ANALYSIS 222
10.4.1 WOUND CARE MARKET 222
FIGURE 28 WOUND CARE MARKET SHARE BY KEY PLAYER (2021) 222
TABLE 199 WOUND CARE MARKET: DEGREE OF COMPETITION 222
10.4.1.1 Advanced wound care 223
FIGURE 29 GLOBAL WOUND CARE MARKET SHARE FOR ADVANCED WOUND CARE
BY KEY PLAYERS (2021) 223
10.4.1.2 Negative pressure wound therapy (NPWT) 224
FIGURE 30 GLOBAL WOUND CARE MARKET SHARE FOR NPWT BY KEY PLAYER (2021) 224
10.4.1.3 Advanced wound dressings 224
FIGURE 31 GLOBAL WOUND CARE MARKET RANKING FOR ADVANCED WOUND DRESSINGS, BY KEY PLAYER, 2021 224
10.4.1.4 Surgical sutures 225
FIGURE 32 GLOBAL WOUND CARE MARKET RANKING FOR SURGICAL SUTURES, BY KEY PLAYER, 2021 225
10.4.1.5 Debridement devices 225
FIGURE 33 GLOBAL WOUND CARE MARKET RANKING FOR DEBRIDEMENT DEVICES,
BY KEY PLAYER, 2021 225
10.4.1.6 Traditional and surgical wound care product markets 226
TABLE 200 GLOBAL WOUND CARE MARKET RANKING FOR TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS, BY KEY PLAYER, 2021 226
10.5 COMPANY EVALUATION QUADRANT 226
10.5.1 LIST OF EVALUATED VENDORS 226
10.5.2 STARS 226
10.5.3 EMERGING LEADERS 226
10.5.4 PERVASIVE PLAYERS 226
10.5.5 PARTICIPANTS 227
FIGURE 34 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 227
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021) 228
10.6.1 PROGRESSIVE COMPANIES 228
10.6.2 STARTING BLOCKS 228
10.6.3 RESPONSIVE COMPANIES 228
10.6.4 DYNAMIC COMPANIES 228
FIGURE 35 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 229
10.7 COMPETITIVE BENCHMARKING 230
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 230
FIGURE 36 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET 230
TABLE 201 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 230
TABLE 202 COMPANY PRODUCT & SERVICE FOOTPRINT 231
TABLE 203 COMPANY REGIONAL FOOTPRINT 231
TABLE 204 WOUND CARE MARKET: DETAILED LIST OF KEY START-UPS/SMES 231
10.8 COMPETITIVE SCENARIO 232
10.8.1 PRODUCT LAUNCHES 232
TABLE 205 KEY PRODUCT LAUNCHES & 232
10.8.2 DEALS 233
TABLE 206 KEY DEALS 233

 

ページTOPに戻る


 

Summary

The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spendings on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market.
“The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period”
The wound care market is segmented into advanced wound care products, surgical wound care products and traditional wound care products. In 2021, the advanced wound care products segment accounted for the highest growth rate in the wound care market. Increasing incidence of traumatic and surgical wounds are major factor contributing to the growth of this segment.
“The diabetic foot ulcers segment accounted for the highest growth rate in the wound care market, by wound type, during the forecast period”
The wound care market is segmented into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers and burns & other wounds based on wound type. In 2021, the diabetic foot ulcers segment accounted for the highest growth rate in the wound care market. Rising technological advancements In the development of cancer biomarkers and increasing incidence of diabetes and other health conditions are major factors contributing to the growth of this segment.
“Hospitals and clinics segment accounted for the highest share”
Based on end users, the wound care market has been segmented into hospitals and clinics, long-term patient care, home care settings and other end users. In 2021, the home care settings segment accounted for the highest CAGR. This can be attributed to the increasing focus on surgical wounds.

“Asia Pacific: The fastest-growing region in wound care market”
The global wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Rising focus on decreasing the surgical wounds and increased focus on traumatic wound management are driving the growth of the wound care market in this region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%
• By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

• 3M Company (US)
• Smith & Nephew PLC (UK)
• Cardinal Health (US)
• Medtronic PLC (Ireland)
• B. Braun Melsungen AG (Germany)
• Baxter International, Inc. (US)
• Mölnlycke Health Care AB (Sweden)
• Convatec Group (UK)
• Paul Hartmann AG (Germany)
• Coloplast A/S (Denmark)
• Organogenesis Holdings Inc. (US)
• MiMedx Group, Inc. (US)
• Integra Life Sciences Holdings Corporation (US)
• Bioventus (US)
• Zimmer Biomet Holdings, Inc. (US)
• Ethicon, Inc. (US)
• DeRoyal Industries (US)
• Kerecis (Iceland)
• Acell (US)
• Lohmann & Rauscher GmbH & Co. KG (Germany)
• Medela Ag (Switzerland)
• Talley Group (UK)
• Welcare Industries SPA (Italy)
• Wuhan VSD Medical Science & Technology Co. Ltd. (China)
• Pensar Medical (US)
• Haromed BVBA (Belgium)
• DermaRite Industries LLC (US)
• Medline Industries, Inc. (US)
• Advancis Medical LLC (UK)
• Mil Laboratories Pvt. Ltd. (India).
Research Coverage:
This report provides a detailed picture of the global wound care market. It aims at estimating the size and future growth potential of the market across different segments, such as products, wound type , end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound care market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.



ページTOPに戻る


Table of Contents

1 INTRODUCTION 35
1.1 OBJECTIVES OF THE STUDY 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS OF THE STUDY 36
1.3 MARKETS COVERED 37
1.3.1 WOUND CARE MARKET 37
1.3.2 YEARS CONSIDERED FOR THE STUDY 38
1.4 CURRENCY 38
1.5 LIMITATIONS 38
1.6 STAKEHOLDERS 39
1.7 SUMMARY OF CHANGES 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
2.2 RESEARCH APPROACH 40
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN METHODOLOGY 40
2.2.1 SECONDARY DATA 41
2.2.1.1 Key data from secondary sources 41
2.2.2 PRIMARY DATA 42
2.2.2.1 Primary sources 42
2.2.2.2 Key data from primary sources 43
2.2.2.3 Key industry insights 44
2.2.2.4 Breakdown of primary interviews 44
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 44
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Approach 1: Company revenue estimation approach 46
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 46
2.3.1.2 Approach 3: Presentations of companies and primary interviews 46
2.3.1.3 Growth forecast 47
2.3.1.4 CAGR projections 47
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47
2.3.2 TOP-DOWN APPROACH 47
FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH 48

2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 49
FIGURE 7 DATA TRIANGULATION METHODOLOGY 49
2.5 MARKET SHARE 50
2.6 ASSUMPTIONS FOR THE STUDY 50
2.7 LIMITATIONS 51
2.8 GROWTH RATE ASSUMPTIONS 51
2.9 RISK ASSESSMENT 51
2.9.1 RISK ASSESSMENT: WOUND CARE MARKET 51
3 EXECUTIVE SUMMARY 52
FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52
FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2022 VS. 2027 (USD MILLION) 53
FIGURE 10 WOUND CARE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53
FIGURE 11 WOUND CARE MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 54
4 PREMIUM INSIGHTS 55
4.1 WOUND CARE MARKET OVERVIEW 55
FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE THE MARKET GROWTH 55
4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2022 VS. 2027 55
FIGURE 13 THE ADVANCED WOUND CARE PRODUCTS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 55
4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2022 VS. 2027 56
FIGURE 14 SURGICAL & TRAUMATIC SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 56
4.4 WOUND CARE MARKET SHARE, BY END USER, 2022 VS. 2027 56
FIGURE 15 THE HOSPITALS AND CLINICS SEGMENT IS EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 56
4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
FIGURE 16 THE ASIA PACIFIC REGION IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 58
5.2.1 DRIVERS 59
5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities 59
5.2.1.1.1 Growing geriatric population 59
5.2.1.1.2 Rising prevalence of diabetes 60
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2019 VS. 2045 (MILLION CASES) 60
5.2.1.1.3 Increasing number of surgical procedures worldwide 60
TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES
PERFORMED IN THE US 61
5.2.2 RISING EXPENDITURE ON CHRONIC WOUNDS 62
5.2.3 INCREASING INCIDENCE OF BURN INJURIES 62
5.2.4 RISING CASES OF TRAUMATIC INJURIES 63
TABLE 2 PREVALENCE OF ROAD ACCIDENTS 63
5.2.5 TECHNOLOGICAL ADVANCEMENTS IN WOUND CARE PRODUCTS 63
5.2.6 RISING USE OF REGENERATIVE MEDICINE FOR WOUND MANAGEMENT 64
5.2.7 RESTRAINTS 65
5.2.7.1 High costs of advanced wound care products 65
TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS 65
5.2.7.2 Risks associated with the use of advanced wound care products 65
TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 66
5.2.8 OPPORTUNITIES 66
5.2.8.1 Growth potential of emerging countries 66
TABLE 5 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC REGION 66
5.2.9 TRENDS 67
5.2.9.1 Acquisitions by leading companies in the market 67
5.2.9.1.1 Rising focus on expanding current technologies and launching novel products 68
5.2.9.1.2 Smart wound dressings for minimum invasiveness 68
5.2.9.1.3 Crab shell bandages 68
5.2.9.1.4 Color-changing dressings 69
5.2.9.1.5 Integration of nanotechnology in advanced wound care products 69
5.2.9.1.6 Novel wound assessment & measurement devices 69
5.3 IMPACT OF COVID-19 ON THE WOUND CARE MARKET 69
5.4 PRICING ANALYSIS 70
TABLE 6 AVERAGE SELLING PRICE OF WOUND CARE PRODUCTS (2022) 70
5.5 PATENT ANALYSIS 71
FIGURE 19 PATENT ANALYSIS OF THE WOUND CARE MARKET 71
5.5.1 LIST OF MAJOR PATENTS 72
5.6 VALUE CHAIN ANALYSIS 72
FIGURE 20 VALUE CHAIN ANALYSIS OF THE WOUND CARE MARKET: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 73
5.7 SUPPLY CHAIN ANALYSIS 73
FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 74
5.8 ECOSYSTEM/MARKET MAP 74
FIGURE 22 WOUND CARE MARKET: ECOSYSTEM/MARKET MAP 75
5.8.1 WOUND CARE MARKET: ECOSYSTEM ROLE 75
5.9 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 7 WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 76
5.9.1 THREAT FROM NEW ENTRANTS 76
5.9.2 THREAT FROM SUBSTITUTES 76
5.9.3 BARGAINING POWER OF BUYERS 76
5.9.4 BARGAINING POWER OF SUPPLIERS 77
5.9.5 DEGREE OF COMPETITION 77
5.10 REGULATORY LANDSCAPE 77
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 11 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
5.10.1 NORTH AMERICA 78
5.10.1.1 US 78
5.10.1.2 Canada 79
5.10.2 EUROPE 79
5.10.3 ASIA PACIFIC 79
5.10.3.1 China 79
5.10.3.2 Japan 79
5.10.3.3 India 79
5.10.4 LATIN AMERICA 79
5.10.4.1 Brazil 80
5.10.4.2 Mexico 80
5.10.5 MIDDLE EAST 80
5.10.6 AFRICA 80
5.11 TRADE ANALYSIS 81
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 81
5.11.1.1 Import data for adhesive dressings by country,
2017–2021 (USD million) 81
5.11.1.2 Export data for adhesive dressings by country,
2017–2021 (USD million) 81
5.12 TECHNOLOGY ANALYSIS 81
5.13 KEY CONFERENCES & EVENTS IN 2022–2023 82
TABLE 12 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 82
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
5.14.1 REVENUE SOURCES ARE SHIFTING TOWARDS TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC 84
5.14.2 REVENUE SHIFT IN THE WOUND CARE MARKET 84
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 85
5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 85
FIGURE 23 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS 85
TABLE 13 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF WOUND CARE PRODUCTS (%) 85
5.15.2 BUYING CRITERIA 86
FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 86
TABLE 14 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 86
5.16 CASE STUDIES 87
5.16.1 CASE STUDY: TIELLE ESSENTIAL SILICONE FOAM DRESSINGS USED IN A NON-HEALING DIABETIC FOOT ULCER ON THE RIGHT FOOT 87
6 WOUND CARE MARKET, BY PRODUCT 88
6.1 INTRODUCTION 89
TABLE 15 WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 89
6.1.1 PRIMARY NOTES 89
6.1.1.1 Key industry insights 89
6.2 ADVANCED WOUND CARE PRODUCTS 90
TABLE 16 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 90
TABLE 17 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 91
6.2.1 ADVANCED WOUND CARE DRESSINGS 91
TABLE 18 ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 92
TABLE 19 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION) 93
6.2.1.1 Foam dressings 93
TABLE 20 KEY PRODUCTS IN THE FOAM DRESSINGS MARKET 93
TABLE 21 FOAM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 22 FOAM DRESSINGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
6.2.1.1.1 Silicone dressings 95
6.2.1.1.1.1 Silicone dressings help expedite wound closure and reduce the risk of maceration – a key factor driving the market growth 95
TABLE 23 SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
6.2.1.1.2 Non-silicone dressings 97
6.2.1.1.2.1 Non-silicone dressings are effective in scar removal and wound healing 97
TABLE 24 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
6.2.1.2 Hydrocolloid dressings 98
6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment which is required for optimal healing 98
TABLE 25 KEY PRODUCTS IN THE HYDROCOLLOID DRESSINGS MARKET 98
TABLE 26 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 99
6.2.1.3 Film dressings 99
6.2.1.3.1 The non-absorbable nature of film dressings ensures strong adoption 99
TABLE 27 FILM DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.2.1.4 Alginate dressings 100
6.2.1.4.1 Alginate dressings are well suited for diabetic & foot ulcers 100
TABLE 28 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
6.2.1.5 Hydrogel dressings 102
6.2.1.5.1 Hydrogel dressings are available in several forms for effective use 102
TABLE 29 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.2.1.6 Collagen dressings 103
6.2.1.6.1 A favorable reimbursement scenario for collagen dressings to support the market growth 103
TABLE 30 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.2.1.7 Hydrofiber dressings 104
6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and collagen 104
TABLE 31 HYDROFIBER DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 105
6.2.1.8 Wound contact layers 105
6.2.1.8.1 Wound contact layers protect wound beds from bacterial & fungal growth 105
TABLE 32 WOUND CONTACT LAYERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 106
6.2.1.9 Superabsorbent dressings 106
6.2.1.9.1 Superabsorbent dressings are designed for highly exuding wounds 106
TABLE 33 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 107
6.2.1.10 Other advanced wound care dressings 107
TABLE 34 OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 109
TABLE 35 ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2020–2027 (USD MILLION) 109
TABLE 36 NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
TABLE 37 ANTIMICROBIAL DRESSINGS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
6.2.2 WOUND THERAPY DEVICES 111
TABLE 38 WOUND THERAPY DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 111
TABLE 39 WOUND THERAPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
6.2.2.1 Portable & conventional negative pressure wound therapy devices (NPWT) 112
6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare to drive the market growth 112
TABLE 40 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 113
6.2.2.2 Debridement devices & accessories 113
6.2.2.2.1 Development of novel technologies to support the growth of this segment 113
TABLE 41 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 114
6.2.2.3 Wound assessment & monitoring devices 115
6.2.2.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost its adoption 115
TABLE 42 WOUND ASSESSMENT & MONITORING MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 115
6.2.3 OTHER DEVICES & ACCESSORIES 116
TABLE 43 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 117
6.2.4 GRAFTS & MATRICES 117
6.2.4.1 Grafts & matrices promote healing & wound closure 117
TABLE 44 KEY PRODUCTS IN THE GRAFTS & MATRICES MARKET 118
TABLE 45 GRAFTS & MATRICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
6.2.5 TOPICAL AGENTS 119
6.2.5.1 Cost-effectiveness & ease-of-use in home care settings to drive the growth of this segment 119
TABLE 46 TOPICAL AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
6.3 SURGICAL WOUND CARE PRODUCTS 120
TABLE 47 SURGICAL CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 121
TABLE 48 SURGICAL CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
6.3.1 SUTURES 122
6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures drive the market growth 122
TABLE 49 SUTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
6.3.2 STAPLERS 123
6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage; a key factor driving adoption 123
TABLE 50 STAPLERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 124
6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES 125
TABLE 51 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 126
TABLE 52 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION,
2020–2027 (USD MILLION) 127
6.3.3.1 Fibrin-based sealants 127
6.3.3.1.1 Fibrin-based sealants provide better results than sutures, thus driving the product demand 127
TABLE 53 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 128
6.3.3.2 Collagen-based sealants 128
6.3.3.2.1 Collagen-based sealants are used in surgical procedures as an adjunctive to hemostatic agents 128
TABLE 54 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 129
6.3.3.3 Synthetic adhesives 129
6.3.3.3.1 Synthetic adhesives have additional sealing properties than traditional staples; a key factor driving the segment growth 129
TABLE 55 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
6.4 TRADITIONAL WOUND CARE PRODUCTS 131
TABLE 56 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 131
TABLE 57 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 132
6.4.1 MEDICAL TAPES 132
6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients 132
TABLE 58 MEDICAL TAPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
6.4.2 DRESSINGS 133
6.4.2.1 Presence of a large patient population for pressure ulcers has ensured a sustained demand for these products 133
TABLE 59 DRESSINGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
6.4.3 CLEANSING AGENTS 134
6.4.3.1 High risk of HAIs from open wounds to drive the market growth 134
TABLE 60 TYPES OF CLEANSING AGENTS 135
TABLE 61 CLEANSING AGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
7 WOUND CARE MARKET, BY WOUND TYPE 136
7.1 INTRODUCTION 137
TABLE 62 WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION) 137
7.2 SURGICAL & TRAUMATIC WOUNDS 137
7.2.1 THE RISING VOLUME OF SURGICAL PROCEDURES DRIVES THE GROWTH OF THIS SEGMENT 137
TABLE 63 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,
BY COUNTRY, 2020–2027 (USD MILLION) 138
7.3 DIABETIC FOOT ULCERS 139
7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT 139
TABLE 64 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN
2021 (20-79 AGE GROUP) 139
TABLE 65 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 140
7.4 PRESSURE ULCERS 140
7.4.1 GROWING GERIATRIC POPULATION TO DRIVE THE GROWTH OF THIS SEGMENT 140
TABLE 66 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 142
7.5 VENOUS LEG ULCERS 142
7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE THE GROWTH OF THIS SEGMENT 142
TABLE 67 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY,
2020–2027 (USD MILLION) 143

7.6 BURNS AND OTHER WOUNDS 144
7.6.1 HIGH INCIDENCE OF BURN INJURIES TO DRIVE THE MARKET GROWTH 144
TABLE 68 WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY,
2020–2027 (USD MILLION) 145
8 WOUND CARE MARKET, BY END USER 146
8.1 INTRODUCTION 147
TABLE 69 WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 147
8.2 HOSPITALS AND CLINICS 147
TABLE 70 TOTAL NUMBER OF HOSPITALS, BY COUNTRY (IN 2019) 148
TABLE 71 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 72 WOUND CARE MARKET FOR HOSPITALS AND CLINICS, BY TYPE,
2020–2027 (USD MILLION) 149
8.2.1 INPATIENT SETTINGS 150
8.2.1.1 Increasing hospital admissions due to HAIs to drive the growth of this segment 150
TABLE 73 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 150
8.2.2 OUTPATIENT SETTINGS 151
8.2.2.1 Rising costs of inpatient facilities drive the demand for outpatient care settings 151
TABLE 74 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 151
8.3 HOME CARE SETTINGS 152
8.3.1 LOW COSTS AND CONVENIENCE TO DRIVE THE GROWTH OF
THIS END-USER SEGMENT 152
TABLE 75 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2020–2027 (USD MILLION) 153
8.4 LONG-TERM CARE FACILITIES 153
8.4.1 GROWTH IN THE GERIATRIC & VULNERABLE POPULATIONS DRIVES THE DEMAND FOR BETTER LONG-TERM CARE 153
TABLE 76 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION) 154
8.5 OTHER END USERS 154
TABLE 77 WOUND CARE MARKET FOR OTHER END-USERS, BY COUNTRY,
2020–2027 (USD MILLION) 155
9 WOUND CARE MARKET, BY REGION 156
9.1 INTRODUCTIONS 157
TABLE 78 WOUND CARE MARKET, BY REGION, 2020–2027 (USD MILLION) 157
9.2 NORTH AMERICA 157
FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT 158
TABLE 79 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 159
TABLE 80 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 159
TABLE 81 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 159
TABLE 82 NORTH AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 160
TABLE 83 NORTH AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 160
TABLE 84 NORTH AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 161
TABLE 85 NORTH AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 161
TABLE 86 NORTH AMERICA: WOUND CARE MARKET; BY TISSUES ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 162
TABLE 87 NORTH AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 162
TABLE 88 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 162
TABLE 89 NORTH AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 163
9.2.1 US 163
9.2.1.1 Rising incidence of chronic diseases and diabetes to
drive the market growth 163
TABLE 90 US: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 163
TABLE 91 US: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 164
9.2.2 CANADA 164
9.2.2.1 High prevalence of HAIs drives the market growth for wound care management in Canada 164
TABLE 92 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029 164
TABLE 93 CANADA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 94 CANADA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 165
9.3 EUROPE 166
TABLE 95 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP) 166
TABLE 96 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045 167
TABLE 97 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 167
TABLE 98 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 168
TABLE 99 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 168
TABLE 100 EUROPE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 169
TABLE 101 EUROPE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 169
TABLE 102 EUROPE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 170
TABLE 103 EUROPE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 170
TABLE 104 EUROPE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 171
TABLE 105 EUROPE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 171
TABLE 106 EUROPE: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 171
TABLE 107 EUROPE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 172
9.3.1 GERMANY 172
9.3.1.1 The large diabetic population in Germany has supported product development & commercialization for the wound care market 172
TABLE 108 GERMANY: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 173
TABLE 109 GERMANY: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 173
9.3.2 FRANCE 173
9.3.2.1 The rising senior population drives the market growth in France 173
TABLE 110 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 174
TABLE 111 FRANCE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 174
9.3.3 UK 174
9.3.3.1 Rising incidence of chronic wounds to propel market growth in the UK 174
TABLE 112 UK: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 113 UK: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 175
9.3.4 ITALY 176
9.3.4.1 Growth in this market is driven by improving quality & accessibility to medical care and products 176
TABLE 114 ITALY: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 176
TABLE 115 ITALY: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 177
9.3.5 SPAIN 177
9.3.5.1 Increasing life expectancies and the growing geriatric population to ensure the market growth in Spain 177
TABLE 116 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178
TABLE 117 SPAIN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 178
9.3.6 RUSSIA 178
9.3.6.1 Government focus on increasing diabetes awareness to favor the market growth 178
TABLE 118 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 179
TABLE 119 RUSSIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 179
9.3.7 REST OF EUROPE 179
TABLE 120 ROE: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 121 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE
PRODUCTS, 2020–2027 (USD MILLION) 180
TABLE 122 ROE: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 181
TABLE 123 ROE: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 181
TABLE 124 ROE: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 182
TABLE 125 ROE: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 182
TABLE 126 ROE: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 183
TABLE 127 ROE: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 183
TABLE 128 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2020–2027 (USD MILLION) 183
TABLE 129 ROE: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 184
9.4 ASIA PACIFIC 184
FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT 185
TABLE 130 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 186
TABLE 131 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 186
TABLE 132 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 186
TABLE 133 ASIA PACIFIC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 187
TABLE 134 ASIA PACIFIC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 187
TABLE 135 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 188
TABLE 136 ASIA PACIFIC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 188
TABLE 137 ASIA PACIFIC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 189
TABLE 138 ASIA PACIFIC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 189
TABLE 139 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 189
TABLE 140 ASIA PACIFIC: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 190
9.4.1 CHINA 190
9.4.1.1 Increasing incidence of DFUs to support the market growth in China 190
TABLE 141 CHINA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 191
TABLE 142 CHINA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 191
9.4.2 JAPAN 191
9.4.2.1 Implementations of regulations in Japan have resulted in a favorable environment for wound care devices 191
TABLE 143 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 192
TABLE 144 JAPAN: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 192
9.4.3 INDIA 193
9.4.3.1 Growing medical tourism in India to support the market growth for wound care management 193
TABLE 145 INDIA: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 193
TABLE 146 INDIA: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 194
9.4.4 AUSTRALIA 194
9.4.4.1 Increasing initiatives to spread awareness on effective wound care to support the market growth 194
TABLE 147 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 195
TABLE 148 AUSTRALIA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 195
9.4.5 SOUTH KOREA 195
9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for advanced wound care products; a key growth driver 195
TABLE 149 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 196
TABLE 150 SOUTH KOREA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 196
9.4.6 SINGAPORE 196
9.4.6.1 The growing prevalence of diabetes drives the market growth in Singapore 196
TABLE 151 SINGAPORE: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 197
TABLE 152 SINGAPORE: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 197
9.4.7 REST OF ASIA PACIFIC 197
TABLE 153 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 198
TABLE 154 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 198
TABLE 155 ROAPAC: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 199
TABLE 156 ROAPAC: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 199
TABLE 157 ROAPAC: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 200
TABLE 158 ROAPAC: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 200
TABLE 159 ROAPAC: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 201
TABLE 160 ROAPAC: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 201
TABLE 161 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 201
TABLE 162 ROAPAC: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 202
9.5 LATIN AMERICA 202
TABLE 163 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 202
TABLE 164 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 203
TABLE 165 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 203
TABLE 166 LATIN AMERICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 204
TABLE 167 LATIN AMERICA: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 204
TABLE 168 LATIN AMERICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 205
TABLE 169 LATIN AMERICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 205
TABLE 170 LATIN AMERICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 206
TABLE 171 LATIN AMERICA: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 206
TABLE 172 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 206
TABLE 173 LATIN AMERICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 207
9.5.1 BRAZIL 207
9.5.1.1 Brazil is the largest healthcare market in Latin America 207
TABLE 174 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 207
TABLE 175 BRAZIL: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 208
9.5.2 MEXICO 208
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico 208
TABLE 176 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 208
TABLE 177 MEXICO: WOUND CARE MARKET, BY END USER, 2020–2027 (USD MILLION) 209
9.5.3 REST OF LATIN AMERICA 209
TABLE 178 ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 209
TABLE 179 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 210
TABLE 180 ROLATAM: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 210
TABLE 181 ROLATAM: WOUND CARE MARKET, BY FOAM DRESSINGS,
2020–2027 (USD MILLION) 211
TABLE 182 ROLATAM: WOUND CARE MARKET, BY WOUND THERAPY DEVICES,
2020–2027 (USD MILLION) 211
TABLE 183 ROLATAM: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 212
TABLE 184 ROLATAM: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 212
TABLE 185 ROLATAM: WOUND CARE MARKET, BY TRADITIONAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 212
TABLE 186 ROLATAM: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 213
TABLE 187 ROLATAM: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 213

9.6 MIDDLE EAST & AFRICA 213
9.6.1 RISING PREVALENCE OF DIABETES IN THE REGION TO SUPPORT
THE MARKET GROWTH 213
TABLE 188 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 214
TABLE 189 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 214
TABLE 190 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY ADVANCED WOUND CARE DRESSINGS, 2020–2027 (USD MILLION) 215
TABLE 191 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY FOAM DRESSINGS, 2020–2027 (USD MILLION) 215
TABLE 192 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND THERAPY DEVICES, 2020–2027 (USD MILLION) 216
TABLE 193 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY SURGICAL WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 216
TABLE 194 MIDDLE EAST & AFRICA: WOUND CARE MARKET; BY TISSUES, ADHESIVES, SEALANTS, AND GLUES; 2020–2027 (USD MILLION) 217
TABLE 195 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY TRADITIONAL
WOUND CARE PRODUCTS, 2020–2027 (USD MILLION) 217
TABLE 196 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE,
2020–2027 (USD MILLION) 217
TABLE 197 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER,
2020–2027 (USD MILLION) 218
10 COMPETITIVE LANDSCAPE 219
10.1 OVERVIEW 219
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 219
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE WOUND CARE MARKET 219
TABLE 198 OVERVIEW OF STRATEGIES DEPLOYED BY KEY WOUND CARE MANUFACTURING COMPANIES 219
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 221
FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET 221
10.4 MARKET SHARE ANALYSIS 222
10.4.1 WOUND CARE MARKET 222
FIGURE 28 WOUND CARE MARKET SHARE BY KEY PLAYER (2021) 222
TABLE 199 WOUND CARE MARKET: DEGREE OF COMPETITION 222
10.4.1.1 Advanced wound care 223
FIGURE 29 GLOBAL WOUND CARE MARKET SHARE FOR ADVANCED WOUND CARE
BY KEY PLAYERS (2021) 223
10.4.1.2 Negative pressure wound therapy (NPWT) 224
FIGURE 30 GLOBAL WOUND CARE MARKET SHARE FOR NPWT BY KEY PLAYER (2021) 224
10.4.1.3 Advanced wound dressings 224
FIGURE 31 GLOBAL WOUND CARE MARKET RANKING FOR ADVANCED WOUND DRESSINGS, BY KEY PLAYER, 2021 224
10.4.1.4 Surgical sutures 225
FIGURE 32 GLOBAL WOUND CARE MARKET RANKING FOR SURGICAL SUTURES, BY KEY PLAYER, 2021 225
10.4.1.5 Debridement devices 225
FIGURE 33 GLOBAL WOUND CARE MARKET RANKING FOR DEBRIDEMENT DEVICES,
BY KEY PLAYER, 2021 225
10.4.1.6 Traditional and surgical wound care product markets 226
TABLE 200 GLOBAL WOUND CARE MARKET RANKING FOR TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS, BY KEY PLAYER, 2021 226
10.5 COMPANY EVALUATION QUADRANT 226
10.5.1 LIST OF EVALUATED VENDORS 226
10.5.2 STARS 226
10.5.3 EMERGING LEADERS 226
10.5.4 PERVASIVE PLAYERS 226
10.5.5 PARTICIPANTS 227
FIGURE 34 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 227
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021) 228
10.6.1 PROGRESSIVE COMPANIES 228
10.6.2 STARTING BLOCKS 228
10.6.3 RESPONSIVE COMPANIES 228
10.6.4 DYNAMIC COMPANIES 228
FIGURE 35 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021 229
10.7 COMPETITIVE BENCHMARKING 230
10.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS 230
FIGURE 36 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET 230
TABLE 201 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 230
TABLE 202 COMPANY PRODUCT & SERVICE FOOTPRINT 231
TABLE 203 COMPANY REGIONAL FOOTPRINT 231
TABLE 204 WOUND CARE MARKET: DETAILED LIST OF KEY START-UPS/SMES 231
10.8 COMPETITIVE SCENARIO 232
10.8.1 PRODUCT LAUNCHES 232
TABLE 205 KEY PRODUCT LAUNCHES & 232
10.8.2 DEALS 233
TABLE 206 KEY DEALS 233

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(金融)の最新刊レポート

MarketsandMarkets社の金融分野での最新刊レポート

本レポートと同じKEY WORD(wound care)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る